-
EP3719124
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3719124
| EP3719124 - INHIBITOR OF THE EXPRESSION OF CANCER-PROMOTING FACTORS, SCREENING METHOD FOR ACTIVE INGREDIENT THEREOF, EXPRESSION CASSETTE USEFUL IN SAID METHOD, DIAGNOSTIC DRUG, AND DIAGNOSTIC METHOD [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 10.11.2023 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 04.09.2020 | ||
| Former | The international publication has been made Status updated on 18.05.2019 | Most recent event Tooltip | 12.03.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states National University Corporation Tokyo Medical and Dental University 1-5-45 Yushima Bunkyo-ku Tokyo 113-8510 / JP | For all designated states Nippon Zoki Pharmaceutical Co., Ltd. 1-2 Hiranomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-0046 / JP | [2020/41] | Inventor(s) | 01 /
ASAHARA, Hiroshi c/o National University Corporation Tokyo Medical and Dental University 1-5-45 Yushima Bunkyo-ku Tokyo 113-8510 / JP | 02 /
CHIBA, Tomoki c/o National University Corporation Tokyo Medical and Dental University 1-5-45 Yushima Bunkyo-ku Tokyo 113-8510 / JP | 03 /
ABE, Kentaro c/o NIPPON ZOKI PHARMACEUTICAL CO. LTD. 1-2 Hiranomachi 2-chome Chuo-ku Osaka-shi Osaka 541-0046 / JP | [2020/41] | Representative(s) | Müller-Boré & Partner Patentanwälte PartG mbB Friedenheimer Brücke 21 80639 München / DE | [2020/41] | Application number, filing date | 18876883.2 | 09.11.2018 | [2020/41] | WO2018JP41758 | Priority number, date | JP20170216747 | 09.11.2017 Original published format: JP 2017216747 | [2020/41] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019093502 | Date: | 16.05.2019 | Language: | JA | [2019/20] | Type: | A1 Application with search report | No.: | EP3719124 | Date: | 07.10.2020 | Language: | EN | [2020/41] | Search report(s) | International search report - published on: | JP | 16.05.2019 | (Supplementary) European search report - dispatched on: | EP | 30.07.2021 | Classification | IPC: | C12N15/09, A61K45/00, A61K48/00, A61P35/00, C12Q1/06, C12Q1/6897, G01N33/15, G01N33/50, G01N33/68 | [2020/41] | CPC: |
C12Q1/6886 (EP,IL);
G01N33/5011 (EP,IL,US);
C12Q1/6897 (EP,IL,KR);
A61K31/7088 (IL,KR);
A61P35/00 (EP,IL,KR);
C12N15/113 (IL,KR);
C12N15/85 (IL,KR);
C12Y113/12007 (IL,US);
G01N33/15 (IL,KR);
G01N33/50 (IL,KR);
G01N33/5023 (EP,IL);
G01N33/574 (EP,IL);
G01N33/68 (IL,KR);
C12N2310/11 (IL,US);
C12N2310/14 (IL,US);
C12N2310/141 (IL,US);
C12Q2527/125 (IL,KR);
C12Q2600/118 (EP,IL);
C12Q2600/136 (EP,IL);
C12Q2600/156 (EP,IL);
C12Q2600/158 (EP,IL);
G01N2500/10 (IL,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/41] | Title | German: | INHIBITOR DER EXPRESSION VON KREBSFÖRDERNDEN FAKTOREN, SCREENINGVERFAHREN FÜR DIESEN WIRKSTOFF, EXPRESSIONSKASSETTE ZUR VERWENDUNG IN DIESEM VERFAHREN, DIAGNOSTISCHES ARZNEIMITTEL UND DIAGNOSTISCHES VERFAHREN | [2020/41] | English: | INHIBITOR OF THE EXPRESSION OF CANCER-PROMOTING FACTORS, SCREENING METHOD FOR ACTIVE INGREDIENT THEREOF, EXPRESSION CASSETTE USEFUL IN SAID METHOD, DIAGNOSTIC DRUG, AND DIAGNOSTIC METHOD | [2020/41] | French: | INHIBITEUR DE L'EXPRESSION DE FACTEURS FAVORISANT LE CANCER, MÉTHODE DE CRIBLAGE POUR PRINCIPE ACTIF DE CELUI-CI, CASSETTE D'EXPRESSION UTILE DANS LADITE MÉTHODE, MÉDICAMENT DE DIAGNOSTIC ET MÉTHODE DE DIAGNOSTIC | [2020/41] | Entry into regional phase | 08.06.2020 | Translation filed | 08.06.2020 | National basic fee paid | 08.06.2020 | Search fee paid | 08.06.2020 | Designation fee(s) paid | 08.06.2020 | Examination fee paid | Examination procedure | 08.06.2020 | Examination requested [2020/41] | 01.02.2022 | Amendment by applicant (claims and/or description) | 13.11.2023 | Despatch of a communication from the examining division (Time limit: M04) | 11.03.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 20.11.2020 | Renewal fee patent year 03 | 24.11.2021 | Renewal fee patent year 04 | 24.11.2022 | Renewal fee patent year 05 | 24.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2008044787 (AICHI PREFECTURE [JP], et al); | [Y]JP2009159869 (UNIV OF OCCUPATIONAL & ENVIRON); | [XY]US2011053804 (MASSAGUE JOAN [US], et al); | [XY]WO2012046063 (JENKINS PAUL [GB]); | [Y]JP2014518610 ; | [Y]JP2016512032 ; | [Y]WO2016106404 (NITTO DENKO CORP [JP], et al); | [Y]WO2016161361 (NANTBIOSCIENCE INC [US], et al); | [AP]WO2017195809 (UNIV NAT CORP TOKYO MEDICAL & DENTAL [JP], et al); |